FluoGuide A/S
STO: FLUO.ST0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Stockholm Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Morten Albrechtsen
- Employees
- 7
- Headquarters
- Copenhagen, Denmark
- IPO year
- 2019
- Market cap
- SEK 588.5M
- Website
- https://fluoguide.com
Loading FLUO…
Loading profile data…Frequently asked questions about FLUO
What does FluoGuide A/S (FLUO.ST) do?
FluoGuide A/S, a life science company, engages in the development and sale of surgical solutions in Denmark. Its lead product candidate is FG001, which is in Phase I/II for the treatment of high-grade glioma, as well as Phase II clinical trial for the treatment of lung cancer. The company also develops FG002, which is in preclinical stage that a...
Where does FLUO.ST trade?
FluoGuide A/S (FLUO.ST) trades on the Stockholm Stock Exchange.
What sector is FLUO.ST in?
FluoGuide A/S (FLUO.ST) operates in the Healthcare sector, specifically in the Medical - Instruments & Supplies industry.
Who is the CEO of FluoGuide A/S?
Morten Albrechtsen is the chief executive officer of FluoGuide A/S (FLUO.ST).
Where is FluoGuide A/S headquartered?
FluoGuide A/S is headquartered in Denmark.
Does FLUO.ST pay a dividend?
FluoGuide A/S (FLUO.ST) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did FLUO.ST go public?
FluoGuide A/S (FLUO.ST) completed its initial public offering in 2019.